The National Nuclear Security Administration is awarding NorthStar Medical Radioisotopes, LLC, with a second tranche of funding aimed at accelerating production of Molybdenum-99, a critical medical isotope. The NNSA said yesterday that it is providing $10.9 million…
Partner Content
Jobs